Aktuelle Studien kommentiert

Ärzte finden hier aktuelle  Publikationen zum Thema maligner Aszites mit einer Einordnung zu ihrer klinischen Relevanz.

 

• Bellot P et al. Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol. 2013; 58(5):922-7
   
• Colombo N et al. A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites. Gynecol Oncol 2012; 125(1): 42-7
   
• Shoji T et al. Pilot study of intraperitoneal administration of triamcinolone acetonide for cancerous ascites in patients with end-stage gynecological cancer. Int J Gynecol Cancer 2014; 24(6): 1093-7
   
• Thomas MN et al. Automated low flow pump system for the treatment of refractory ascites: a single-center experience. Langenbecks Arch Surg. 2015; 400(8): 979-83
   
• Woopen H, Sehouli J. Current and future options in the treatment of malignant ascites in ovarian cancer. Anticancer Res. 2009; 29(8):3353-9